| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,412 |
3,086 |
$348K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,887 |
1,473 |
$96K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
568 |
531 |
$26K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
486 |
439 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
485 |
453 |
$13K |
| 93000 |
|
560 |
525 |
$12K |
| 94010 |
|
307 |
281 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
95 |
88 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
44 |
29 |
$4K |
| 95924 |
|
21 |
13 |
$2K |
| 95923 |
|
21 |
13 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
16 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
13 |
$328.44 |